| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| trilaciclib | cyclin-dependent kinase 2 | small molecule | NA | drugbank , DGIDB | Small cell carcinoma of lung[MeSHID:D055752] Triple Negative Breast Neoplasms[MeSHID:D064726] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved,investigational | inhibitor |
| trilaciclib | cyclin-dependent kinase 4 | small molecule | Successful target | TTD , drugbank , DGIDB | Small cell carcinoma of lung[MeSHID:D055752] Triple Negative Breast Neoplasms[MeSHID:D064726] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.68 | approved,investigational | inhibitor |
| trilaciclib | cyclin-dependent kinase 5 | small molecule | NA | drugbank | Small cell carcinoma of lung[MeSHID:D055752] Triple Negative Breast Neoplasms[MeSHID:D064726] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| trilaciclib | cyclin-dependent kinase 6 | small molecule | Successful target | TTD , drugbank , DGIDB | Small cell carcinoma of lung[MeSHID:D055752] Triple Negative Breast Neoplasms[MeSHID:D064726] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.18 | approved,investigational | inhibitor |
| trilaciclib | cyclin-dependent kinase 7 | small molecule | NA | drugbank , DGIDB | Small cell carcinoma of lung[MeSHID:D055752] Triple Negative Breast Neoplasms[MeSHID:D064726] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.41 | approved,investigational | inhibitor |
| trilaciclib | cyclin-dependent kinase 9 | small molecule | NA | drugbank , DGIDB | Small cell carcinoma of lung[MeSHID:D055752] Triple Negative Breast Neoplasms[MeSHID:D064726] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.41 | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||